![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](bt2574contents.gif)
Acta Cryst. (2007). E63, m2940 [ doi:10.1107/S1600536807054852 ]
2-acetato-1:2
3O,O':O;2:3
3O:O,O'-tetrakis(
2-2-hydroxybenzoato)-1:2
4O:O';2:3
4O:O'-bis(1,10-phenanthroline)-1
2N,N';3
2N,N'-trizinc(II)Abstract: The centrosymmetric trinuclear title compound, [Zn3(C2H3O2)2(C7H5O3)4(C12H8N2)2], has six carboxylate groups each bridging two metal centers. The Zn atom on a center of inversion is coordinated by six O atoms in an octahedral environment. The other Zn atoms are each chelated by the N-heterocycle, and their coordination number is also six as the acetate group also functions as a chelating group. The hydroxy group of one of the two symmetry-independent salicylate groups is disordered over two positions in a 2:1 ratio.
Online 9 November 2007
Copyright © International Union of Crystallography
IUCr Webmaster